AUTONOMIX MEDICAL INC (AMIX)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$4.59-1.92%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · AMIX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Model as of 2026-09-04 · Compared with 88 industry peers · Company calendar date is not available
AMIX — capital allocation — Unregistered Sales of Equity Securities
Dated 2026-08-26
Unregistered Sales of Equity Securities. The Company issued the New Warrants pursuant to the exemption from the registration requirements of the Securities Act available under Section 4(a)(2). Neither the issuance of the New Warrants nor the New Warrant Shares will be registered under the Securities Act, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act and any applicable state securities laws. Th…
Why it matters: Better control of operating losses may show improved efficiency. This is key for survival.
Supportive ifOperating losses drop a lot compared to past quarters.
Worry ifOperating losses stay the same or go up. This shows ongoing financial problems.
Why it matters: Good capital management is important due to ongoing losses. This affects future funding and growth.
Watch forManagement shares a clear plan for capital allocation. It shows steps to move forward.
Also watch forInvestors are worried. There are no updates or unclear plans for capital allocation.
Why it matters: If revenue growth picks up, it could signal a stronger market for Autonomix Medical.
Supportive if3-year revenue growth in the health care sector increases back toward 12% or higher.
Worry ifRevenue growth over the last 3 years is below 9%. It may keep slowing down.
Why it matters: The company faces a listing deficiency due to its stock price. Staying compliant is crucial for its future.
Worry ifA public announcement says the stock price has been above $1.00 for 30 days.
Less concerning ifAnother Nasdaq letter is sent because the stock price is below $1.00.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$426 on $10,000 · ±4.3% | How much price usually moves either way. |
| Bad day | $1,236 loss on $10,000 · 12.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,961 loss on $10,000 · 89.6% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Continued high cash burn could signal ongoing financial distress. Investors will want to see improvement.
Worry ifCash burn decreases significantly from $3.54 million in Q2 2026 to below $2 million in Q3 2026.
Less concerning ifCash burn stays above $3 million in Q3 2026. This shows ongoing financial trouble.
Why it matters: The reverse stock split aims to help maintain Nasdaq compliance and could impact investor perception.
Watch forStock price stabilizes or increases after the reverse split on June 24, 2026.
Also watch forThe stock price drops a lot after the reverse split.
Why it matters: The reverse stock split may change how easily shares can be traded. It might show financial trouble or a way to meet Nasdaq rules.
Watch forAfter the split, trading volume goes up a lot. This shows that investors are interested again.
Also watch forTrading volume goes down or stays low. This means investors are still unsure.
Why it matters: Staying on the Nasdaq list is important for Autonomix. It helps them raise money and get investors.
Supportive ifManagement shares a plan to fix the listing issue before the next quarterly report.
Worry ifThere are no updates on compliance efforts or new notices from Nasdaq.
Why it matters: Keeping the Nasdaq listing is important for investor trust and getting funds.
Supportive ifManagement says they follow Nasdaq rules after the reverse split.
Worry ifNasdaq issues a warning or delisting notice due to non-compliance.
Why it matters: Finishing this deal shows good money management. It will also bring in $4.9 million.
Supportive ifThe transaction closes on or about August 26, 2026, with funds received.
Worry ifThe transaction fails to close or is delayed beyond the expected date.
Why it matters: Less operating losses mean better money health and cash handling.
Supportive ifOperating losses drop more from negative $2.77 million in Q1 2027.
Worry ifOperating losses get worse or stay the same compared to Q1 2027.